Stockreport

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Shares Could Be 44% Below Their Intrinsic Value Estimate [Yahoo! Finance]

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report
PDF Current share price of US$2.32 suggests Milestone Pharmaceuticals is potentially 44% undervalued The US$3.75 analyst price target for MIST is 9.2% less than our estim [Read more]